Clinical Trial Update: Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study evaluating fixed-dose combination tablets of Saxagliptin/Dapagliflozin/Metformin XR versus the individual components in healthy s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED